您的位置：
首页
>
农业专利
>
详情页
METHODS OF TREATING CANCER USING AURORA KINASE INHIBITORS
专利权人:
INC.;MILLENNIUM PHARMACEUTICALS
发明人:
MILLENNIUM PHARMACEUTICALS, INC.
申请号：
GEAP2013013599
公开号：
GEP20186900B
申请日:
2013.03.19
申请国别(地区):
GE
年份:
2018
代理人:
摘要：
An invention relates to administering of Aurora A kinase selective inhibitor in combination with paclitaxel at lung carcinoma treatment, in particular dosed regime.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
REGIME POSOLOGIQUE POUR UN INHIBITEUR DE PI-3 KINASE
COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR TREATING OR PREVENTING CANCER, INFLAMMATORY CONDITION, IMMUNOLOGICAL CONDITION OR METABOLIC CONDITION, AND FOR INHIBITING A KINASE IN A DITA KINASE CELL
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors
HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS
IMIDAZO[1,2-B]PYRIDAZINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
